Condensed Interim Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Other Comprehensive Income	Total
Balance beginning at Oct. 31, 2023	$ 2,541,515	$ 141,604,015	$ (138,645,486)	$ 92,248	$ 5,592,292
Balance beginning (in Shares) at Oct. 31, 2023	47,365,652
Stock option activity as follows:
Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12)		82,068			82,068
Net loss			(211,872)		(211,872)
Balance ending at Apr. 30, 2024	$ 2,541,515	141,686,083	(138,857,358)	92,248	5,462,488
Balance ending (in Shares) at Apr. 30, 2024	47,365,652
Balance beginning at Jan. 31, 2024	$ 2,541,515	141,666,852	(138,838,161)	92,248	5,462,454
Balance beginning (in Shares) at Jan. 31, 2024	47,365,652
Stock option activity as follows:
Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12)		19,231			19,231
Net loss			(19,197)		(19,197)
Balance ending at Apr. 30, 2024	$ 2,541,515	141,686,083	(138,857,358)	92,248	5,462,488
Balance ending (in Shares) at Apr. 30, 2024	47,365,652
Balance beginning at Oct. 31, 2024	$ 2,541,515	141,723,305	(138,814,271)	92,248	$ 5,542,797
Balance beginning (in Shares) at Oct. 31, 2024	47,365,652				47,365,652
Issuance of common stock as follow:
Exercise of warrants, net of issuance costs (Note 11)	$ 215	5,763			$ 5,978
Exercise of warrants, net of issuance costs (Note 11) (in Shares)	21,500
Stock option activity as follows:
Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12)		21,329			21,329
Net loss			(172,653)		(172,653)
Balance ending at Apr. 30, 2025	$ 2,541,730	141,750,397	(138,986,924)	92,248	$ 5,397,451
Balance ending (in Shares) at Apr. 30, 2025	47,387,152				47,387,152
Balance beginning at Jan. 31, 2025	$ 2,541,515	141,738,026	(138,916,657)	92,248	$ 5,455,132
Balance beginning (in Shares) at Jan. 31, 2025	47,365,652
Issuance of common stock as follow:
Exercise of warrants, net of issuance costs (Note 11)	$ 215	5,763			5,978
Exercise of warrants, net of issuance costs (Note 11) (in Shares)	21,500
Stock option activity as follows:
Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12)		6,608			6,608
Net loss			(70,267)		(70,267)
Balance ending at Apr. 30, 2025	$ 2,541,730	$ 141,750,397	$ (138,986,924)	$ 92,248	$ 5,397,451
Balance ending (in Shares) at Apr. 30, 2025	47,387,152				47,387,152